Palisade Bio Inc reports results for the quarter ended in June - Earnings Summary

Palisade Bio

14/08/2023 13:01

* Palisade Bio Inc  PALI.OQ  reported a quarterly adjusted
loss
of 53 cents​​ per share for the quarter ended in June. The mean
expectation of two analysts for the quarter was for a loss of 45
cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Palisade Bio Inc's reported EPS for the quarter was a loss
of 53
cents​.
    * The mean earnings estimate of analysts had fallen by
about 1.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Palisade Bio Inc shares had fallen by 58.2% this
quarter and
lost 86.3% so far this year.
    * The company reported a quarterly loss of $3.39 million.
    * Wall Street's median 12-month price target for Palisade
Bio Inc
is $16.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 14 at 12:01 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.45          -0.53          Missed
 Mar. 31 2023      -0.72          -0.54          Beat
 Dec. 31 2022      -2.43          6.47           Beat
 Sep. 30 2022      -4.00          -4.00          Met